Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis

Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis

Show other versions (1)

Oral third-generation cephalosporins (3GCs) are not recommended for use owing to their low bioavailability and the risk of emergence of resistant microorganisms with overuse. A standardized and effective method for reducing their use is lacking. Here, in a 60-month, single-institution, interrupted t...

Full description

Bibliographic Details
Main Authors: Naoya Itoh, Takanori Kawabata, Nana Akazawa, Daichi Kawamura, Hiromi Murakami, Yuichi Ishibana, Eiichi N. Kodama, Norio Ohmagari
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910666/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910666/?tool=EBI

Similar Items